Author: OurCrowd

[EquipmentShare in EquipmentShare] EquipmentShare pitches in to help St. Louis recover after tornado

Jun 25, 2025 |

On the afternoon of Friday, May 16, a mile-wide EF3 tornado tore through St. Louis, killing five people and causing an estimated $1.6 billion in damages. As soon as the storm passed, the question for EquipmentShare team members — from the local branches in St. Louis to corporate headquarters 125 miles west in Columbia, Missouri — wasn’t whether they would help but rather how they could do the most good. Read...

Read More

[ThetaRay in BusinessWire] I&M Bank partners with ThetaRay to deploy full cognitive AI financial crime compliance platform across east africa

Jun 25, 2025 |

NAIROBI, Kenya & NEW YORK–(BUSINESS WIRE)–ThetaRay, a global leader in Cognitive AI financial crime compliance, today announced a landmark partnership with I&M Group PLC, a leading Regional Financial Services Group in Africa. The partnership will see the deployment of ThetaRay’s advanced AML (Anti-Money Laundering) platform across I&M Group’s operations in Kenya, Tanzania, Rwanda, Uganda, and Mauritius. Read more...

Read More

[Ingressive Capital Fund in Techawk] Nowlun raises $600K from Ingressive Capital

Jun 24, 2025 |

Nowlun, the digital logistics platform that simplifies global freight in the MENA region by helping businesses move full container load (FCL) and bulk cargo with speed and simplicity, and keeps them on top of every move with real-time tracking and instant updates, has closed its seed round at $2.3 million following a $600K extension led by Ingressive Capital, a prominent African VC. Watch...

Read More

[MeMed in Business Wire] MeMed completes development of first-ever fingerstick host-response test for rapid differentiation of bacterial and viral infections

Jun 24, 2025 |

ANDOVER, Mass. & HAIFA, Israel–(BUSINESS WIRE)–MeMed, a global leader in host-response diagnostics, today announced the completion of its multi-year development of MeMed BV Flex, an innovative, next-generation test designed to expand the reach of MeMed BV® into decentralized, CLIA-waived settings. The test enables accurate differentiation between bacterial and viral infections in just 15 minutes using only a few drops of capillary blood from a finger prick. Read more...

Read More